Expression of nitroreductase gene NOR1 in E.coli and the preparation of antiserum

Chinese Journal of Cancer Research

Volumn 16, Issue 1, 2004, Pages 11-14

  Nie, Xin Min ^a,b   Zhou, Ming ^a   Gui, Rong ^b   Li, Xiao Ling ^a   Zhang, Bi Cheng ^a   Li, Wei Fang ^a   Wang, Rong ^a   Cao, Li ^a   Li, Gui Yuan ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Antiserum preparation; Gene express; Nasopharyngeal carcinoma; Protein purification

Indexed keywords

ANTISERUM; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; RESTRICTION ENDONUCLEASE;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE EXPRESSION; GENE INDUCTION; GENE INSERTION; GENE ISOLATION; GENE SEQUENCE; GENETIC ANALYSIS; IMMUNIZATION; IMMUNOBLOTTING; NITROREDUCTASE GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PURIFICATION; PROTEIN TARGETING; RABBIT; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TITRIMETRY; WESTERN BLOTTING;

EID: 1842634280     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974859     Document Type: Article

References (14)

1. Deng LW, Jiang L, Tan GL, et al. A common region of allelic loss on chromosome region on 3p25.3-26.2 in nasopharyngeal carcinoma [J]. Gene Chromosomes Cancer 1998; 23:21-5.
2. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: a review [J]. Epidemiol Rev 1993; 15: 446-85.
3. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma [J]. Semin Cancer Biol 2002; 12:421-9.
4. Yao KT. Further investigation of experimental induction of nasopharyngeal carcinoma in rats by nitrosopiperazine [J]. Chin Sci Bull 1978; 23:756-8.
5. Hao SP, Tsang NM, Chang KP. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs [J]. Cancer 2003; 97:1909-13.
6. Kumar S, Wairagkar NS, Mahanta J. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma [J]. Indian J Cancer 2001; 38:72-5.
7. Shao JY, Zeng WF, Zeng YX. Molecular genetic progression on nasopharyngeal carcinoma [J]. Chin J Cancer 2002; 21:1-10.
8. Khan J, Simon R, Bittner M, et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays [J]. Cancer Res 1998; 58:5009-13.
9. Wang K, Gan L, Jeffery E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray [J]. Gene 1999; 229:101-8.
10. Sgroi DC, Teng S, Robinson G, et al. In vivo gene expression profile analysis of human breast cancer progression [J]. Cancer Res 1999; 59:5656-61.
11. Parkinson GN, Skelly JV, Neidle S. Crystal structure of FMN-Dependent nitroreductase from Escherichia coli B: a prodrug-activing enzyme [J]. J Med Chem 2000; 43: 3624-31.
12. Green NK, Youngs DJ, Neoptolemos JP, et al. Sensitization of colorectal and pancreatic cancer cells to the prodrug 5-(aziridin-1-yl)-2, 4-dinitrobenzamide (CB 1954) by retroviral transduction and expression of the E.Coli nitroreductase gene [J]. Cancer Gene Ther 1997; 4:229-38.
13. 7 and its expression in E.Coli [J]. Prog Biochem Biophys 2002; 29:631-4.
14. Tan ZP, Huang LQ, Zheng D. Expression and purification of p11 fusion protein in E.coli and preparation of antiserum against GST-p11 [J]. Bull Hunan Med Univ 2002; 27:189-91.